On April 12, 2017, the NYSDFS announced that it has reminded state-authorized health insurers that they must provide coverage for office visits that fall under the insured’s policy of covered services, including those resulting in patients receiving medical marijuana certifications.
Tag Archives: Patients
ALBANY, N.Y., April 12, 2017 /Weed Wire/ — Department of Financial Services is reminding all insurers authorized to write insurance in New York State that they must provide coverage for office visits for covered services, including those that may result in a medical marijuana certification, as long as the visit was not solely for the purpose of the certification.
On April 6, 2017, both chambers of the Indiana Legislature approved measures loosening restrictions on a marijuana-derived oil used to treat epilepsy.
On April 6, 2017, the West Virginia legislature approved Senate Bill 386, a bill legalizing medical marijuana in the state.
According to the Medical Marijuana Trust Fund Annual Report, issued by the Massachusetts Department of Public Health for fiscal year 2016, the state collected approximately $7.2 million in revenue from its medical marijuana program.
SANTA FE, N.M., April 7, 2017 /Weed Wire/ — On Friday, April 7, New Mexico could become the first state in the nation to specifically list opioid use disorder as medical condition that qualifies for access to the state medical marijuana program.
n appellate court ruled Thursday that Arizona colleges and universities can prohibit medical marijuana on campuses but lawmakers can’t make it a crime.
West Virginia’s House voted Tuesday to legalize doctor-prescribed marijuana to treat certain medical conditions following Senate passage of a similar measure last week.
On April 5, 2017, the Illinois Medical Cannabis Pilot Program announced that it brought in approximately $6.3 million in retail medical marijuana sales for the month of March, a nearly $2 million surge from the $4.9 million in sales for the month of February.
In this World of Cannabis Interview, watch Caroline Cahill, Managing Editor of MJINews.com and Marijuana Industry News magazine, interview Steef Fleur, photographer for Green Gold Stories.
Insys Therapeutics dropped after it received disappointing news from the DEA regarding its marijuana drug Syndros.
On April 3, 2017, the Florida Senate Committee on Health Policy voted unanimously to approve Senate Bill 406, a bill regulating the state’s emerging medical marijuana market.
Under federal law, even legal marijuana is illegal. John Oliver explains why conflicting drug laws pose serious problems.
WASHINGTON, April 3, 2017 /Weed Wire/ – On Thursday, Argentina legalized medical marijuana, after the Senate unanimously approved a bill that was already passed by the House of Representatives last November.
Argentina gave final legislative approval on Wednesday to a bill legalizing cannabis oil for medicinal use and permitting the federal government to grow marijuana for research and therapeutic purposes.
On March 28, 2017, the Georgia House approved Senate Bill 16, a bill that would increase the number of conditions eligible for receiving medical marijuana oil as treatment.
On March 28, 2017, the Florida House Health Quality Subcommittee voted to approve a bill that would regulate the state’s burgeoning medical marijuana market.
Online sales could be one way recreational marijuana is sold after legalization. Canopy Growth, the parent company of Tweed, Bedrocan, and Mettrum, is preparing to launch a website that will sell marijuana from all three producers in one place.
On March 27, 2017, members of Maine’s Joint Standing Committee on Health and Human Services heard testimony in favor of LD 764, a bill that would allow medical marijuana patients to receive organ transplants.
The Florida Senate is approximately two weeks away from passing a bill that would regulate its newly minted medical marijuana program.
In Arkansas, House lawmakers have rejected House Bill 1392, a proposal that would have banned the sale of commercial medical marijuana edibles.
Advocates want New Hampshire state legislators to allow medical marijuana use for treatment of a disorder that leaves 1 in 5,000 people in chronic pain.
ALBANY, N.Y., March 16, 2017 /Weed Wire/ — The New York State Department of Health today announced several enhancements to the state’s Medical Marijuana Program that will improve patient access. These measures include authorizing physician assistants to certify patients and adding chronic pain as a qualifying condition.
Should businesses be able to fire workers for using medical marijuana, even if it’s legal under state law? That’s a question that the Massachusetts Legislature is currently considering as it debates a pair of bills that would extend legal protections to medical marijuana patients in the workplace.
Watch the World of Cannabis in Las Vegas tackle the details of medical marijuana state initiatives. Matthew Abel, attorney and director of Michigan NORML, covers recent medical marijuana developments in Michigan. Ari Gerstin, an attorney in Miami, and Michael C. Minardi, Senior Partner at Minardi Law, provide an update on medical marijuana in Florida.
PORTLAND, Maine, March 16, 2017 /Weed Wire/ — Wellness Connection of Maine (WCM), the state’s largest medical cannabis operator, now offers members the ability to pay for cannabis without using cash. A new mobile app, CanPay, is the first of its kind technology for the cannabis industry.
Montana lawmakers are considering a 6 percent sales tax on medical marijuana.
Nebraska state lawmakers are gearing up to tackle a controversial bill: medical marijuana.
SAN DIEGO, Calif., March 14, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico is holding a press conference in Mexico City, Mexico, today to reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.
DEVON, Penn., March 13, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it has completed enrollment in the Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial evaluating ZYN002 cannabidiol (CBD) gel in adult epilepsy patients with refractory focal seizures.
CANBERRA, Australia, March 8, 2017 /Weed Wire/ — Today the Office of Drug control issued the second licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. This is the first commercial medicinal cannabis licence and authorises the cultivation and production of Australian grown cannabis into the manufacture chain and for subsequent therapeutic supply to Australian patients.
NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.
Saturday afternoon, the New Mexico State House voted (41-26) to pass House Bill 155, co-sponsored by Rep. D. Armstrong (D-Albuquerque) and Rep. McCamley (D-Las Cruces) to establish a fund in the state treasury for research related to the production, uses, effects, and efficacy of medical marijuana.
Insys Therapeutics announced a compassionate-use program for its cannabis-based epilepsy drug, igniting optimism that the company is continuing to develop marijuana medicine.
SPRINGFIELD, Ill., March 2, 2017 /Weed Wire/ — The Illinois Department of Public Health (IDPH) has approved applications for approximately 16,990 qualifying patients (including 139 persons under 18 years of age), since it began accepting applications for the Medical Cannabis Registry Program on September 2, 2014.
President of Evoxe Laboratories, Michael Katz, presents this emerging brand’s business model that lead to its current success.
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
On Feb. 23, 2017, the Ohio State Board of Pharmacy released draft regulations for forms and methods of administering medical marijuana, specifically with regards to how much a patient can possess within a 90-day period.
Stephen Goldner, Senior Forensic Toxicologist at Quantum 9, learned early on how to work with the FDA, having developed the FDA-approved liquid dose form of methadone with his mentor John Broich. Hear Goldner discuss what role the FDA would likely play in life after medical cannabis legalization.
HARTFORD, Conn., Feb. 23, 2017 /Weed Wire/ — Today, Commissioner Jonathan A. Harris informed the Board of Physicians of his decision regarding which conditions DCP will seek to add to the list of debilitating conditions through the regulation making process.
On Feb. 22, 2017, Australia’s Department of Health announced that providers approved by the Office of Drug Control will be allowed to import medical marijuana from approved international sources.
As Gov. Chris Christie travels the state on an aggressive campaign to end an epidemic of heroin and prescription drug overdoses, more than two dozen New Jersey citizens came to the capital city Wednesday to offer him a new strategy.
Starting next year, Pennsylvanians with one of 17 qualifying medical conditions will be able to do the same. First, the state must award permits to growers, processors and distributors and competition for those licenses will be fierce. But, does medical marijuana open the door to legalization of recreational pot?
CANBERRA, Australia, Feb. 22, 2017 /Weed Wire/ — The Turnbull Government will facilitate faster access by qualified doctors to medicinal cannabis for patients with the necessary approvals.
The Arkansas Medical Marijuana Commission on Tuesday approved its final rules governing how businesses can cultivate and sell marijuana.
ROHNERT PARK, Calif., Feb. 22, 2017 /Weed Wire/ — Two leaders in California education – United Patients Group, a leading medical cannabis education organization and Sonoma State University are teaming up to offer the first medical cannabis course from a major public university in the country.
PORTLAND, Ore., Feb. 15, 2017 /Weed Wire/ — A report presented this month to the Oregon Legislature, HB 4014 Clinical Guidelines Work Group: Guidelines for Attending Physicians When Recommending the Medical Use of Marijuana, provides recommendations to physicians on appropriate care of a patient diagnosed with one or more debilitating conditions for which the physician is recommending the medical use of marijuana.
HONOLULU, Hawaii, Feb. 14, 2017 /Weed Wire/ – The Hawaii State Department of Health (DOH) today issued a Notice to Proceed to Acquire and Cultivate Marijuana to Pono Life Sciences Maui LLC for their production center on Maui.
NANAIMO, British Columbia, Feb. 14, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary approvals in Canada and New Zealand to export medical cannabis to New Zealand.
In most countries, the authorities arrest anyone growing large quantities of cannabis. But in Italy, the army does something different: it grows the plant itself – for medical use.